Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients
Ishikawa, Takeshi, Kageyama, Shinichi, Miyahara, Yoshihiro, Okayama, Tetsuya, Kokura, Satoshi, Wang, Linan, Sato, Eiichi, Yagita, Hideo, Itoh, Yoshito, Shiku, Hiroshi
Published in Cancer Immunology, Immunotherapy (01.11.2021)
Published in Cancer Immunology, Immunotherapy (01.11.2021)
Get full text
Journal Article
MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours
Ishihara, Mikiya, Kageyama, Shinichi, Miyahara, Yoshihiro, Ishikawa, Takeshi, Ueda, Shugo, Soga, Norihito, Naota, Hiroaki, Mukai, Katsumi, Harada, Naozumi, Ikeda, Hiroaki, Shiku, Hiroshi
Published in BMC cancer (29.06.2020)
Published in BMC cancer (29.06.2020)
Get full text
Journal Article
Venetoclax is effective for chronic myelomonocytic leukemia blastic transformation with RUNX1 mutation
Kashima, Emiko, Sugimoto, Yuka, Nagaharu, Keiki, Ohya, Eiko, Ikejiri, Makoto, Watanabe, Yasuyuki, Kageyama, Shinichi, Oka, Koji, Tawara, Isao
Published in Hematology (Luxembourg) (01.12.2024)
Published in Hematology (Luxembourg) (01.12.2024)
Get full text
Journal Article
Acute Megakaryoblastic Leukemia Harboring a Subclone Expressing BCR-ABL1 Fusion Gene Product
Kashima, Emiko, Nakano, Eri, Watanabe, Yasuyuki, Imai, Hiroshi, Oka, Koji, Kageyama, Shinichi, Tanaka, Isao
Published in Internal Medicine (15.11.2021)
Published in Internal Medicine (15.11.2021)
Get full text
Journal Article
Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high-grade soft-tissue sarcoma
Kakimoto, Takuya, Matsumine, Akihiko, Kageyama, Shinichi, Asanuma, Kunihiro, Matsubara, Takao, Nakamura, Tomoki, Iino, Takahiro, Ikeda, Hiroaki, Shiku, Hiroshi, Sudo, Akihiro
Published in Oncology letters (01.04.2019)
Published in Oncology letters (01.04.2019)
Get full text
Journal Article
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors
Ishihara, Mikiya, Tono, Yasutaka, Miyahara, Yoshihiro, Muraoka, Daisuke, Harada, Naozumi, Kageyama, Shinichi, Sasaki, Takeshi, Hori, Yasuhide, Soga, Norihito, Uchida, Katsunori, Shiraishi, Taizo, Sato, Eiichi, Kanda, Hideki, Mizuno, Toshiro, Webster, Gill A., Ikeda, Hiroaki, Katayama, Naoyuki, Sugimura, Yoshiki, Shiku, Hiroshi
Published in Cancer Immunology, Immunotherapy (01.04.2020)
Published in Cancer Immunology, Immunotherapy (01.04.2020)
Get full text
Journal Article
High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine
Saito, Takuro, Wada, Hisashi, Yamasaki, Makoto, Miyata, Hiroshi, Nishikawa, Hiroyoshi, Sato, Eiichi, Kageyama, Shinichi, Shiku, Hiroshi, Mori, Masaki, Doki, Yuichiro
Published in Vaccine (14.10.2014)
Published in Vaccine (14.10.2014)
Get full text
Journal Article
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome
Ishihara, Mikiya, Kitano, Shigehisa, Kageyama, Shinichi, Miyahara, Yoshihiro, Yamamoto, Noboru, Kato, Hidefumi, Mishima, Hideyuki, Hattori, Hiroyoshi, Funakoshi, Takeru, Kojima, Takashi, Sasada, Tetsuro, Sato, Eiichi, Okamoto, Sachiko, Tomura, Daisuke, Nukaya, Ikuei, Chono, Hideto, Mineno, Junichi, Kairi, Muhammad Faris, Diem Hoang Nguyen, Phuong, Simoni, Yannick, Nardin, Alessandra, Newell, Evan, Fehlings, Michael, Ikeda, Hiroaki, Watanabe, Takashi, Shiku, Hiroshi
Published in Journal for immunotherapy of cancer (01.06.2022)
Published in Journal for immunotherapy of cancer (01.06.2022)
Get full text
Journal Article
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy
Nagata, Yasuhiro, Kageyama, Shinichi, Ishikawa, Takeshi, Kokura, Satoshi, Okayama, Tetsuya, Abe, Tetsuya, Murakami, Masahiko, Otsuka, Koji, Ariyoshi, Tomotake, Kojima, Takashi, Taniguchi, Ken, Kobayashi, Shinichiro, Shimada, Hideaki, Yajima, Satoshi, Suzuki, Takashi, Hirano, Satoshi, Tsuchikawa, Takahiro, Shichinohe, Toshiaki, Ueda, Shugo, Kanetaka, Kengo, Yoneda, Akira, Wada, Hisashi, Doki, Yuichiro, Yamaue, Hiroki, Katsuda, Masahiro, Ohi, Masaki, Yasuda, Hiromi, Kondo, Ken, Kataoka, Masato, Kodera, Yasuhiro, Koike, Masahiko, Shiraishi, Taizo, Miyahara, Yoshihiro, Goshima, Naoki, Fukuda, Eriko, Yamaguchi, Kei, Sato, Eiichi, Ikeda, Hiroaki, Yamada, Tomomi, Osako, Masaharu, Hirai, Kaoru, Miyamoto, Hiroshi, Watanabe, Takashi, Shiku, Hiroshi
Published in Cancer Immunology, Immunotherapy (01.11.2022)
Published in Cancer Immunology, Immunotherapy (01.11.2022)
Get full text
Journal Article
Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel
Kageyama, Shinichi, Kitano, Shigehisa, Hirayama, Michiko, Nagata, Yasuhiro, Imai, Hiroshi, Shiraishi, Taizo, Akiyoshi, Kazunari, Scott, Andrew M., Murphy, Roger, Hoffman, Eric W., Old, Lloyd J., Katayama, Naoyuki, Shiku, Hiroshi
Published in Cancer science (01.03.2008)
Published in Cancer science (01.03.2008)
Get full text
Journal Article
Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial
Okumura, Satoshi, Ishihara, Mikiya, Kiyota, Naomi, Yakushijin, Kimikazu, Takada, Kohichi, Kobayashi, Shinichiro, Ikeda, Hiroaki, Endo, Makoto, Kato, Koji, Kitano, Shigehisa, Matsumine, Akihiko, Nagata, Yasuhiro, Kageyama, Shinichi, Shiraishi, Taizo, Yamada, Tomomi, Horibe, Keizo, Takesako, Kazuto, Miwa, Hiroshi, Watanabe, Takashi, Miyahara, Yoshihiro, Shiku, Hiroshi
Published in BMJ open (14.11.2022)
Published in BMJ open (14.11.2022)
Get full text
Journal Article
Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status
Fujiwara-Kuroda, Aki, Kato, Tatsuya, Abiko, Takehiro, Tsuchikawa, Takahiro, Kyogoku, Noriaki, Ichinokawa, Masaomi, Tanaka, Kimitaka, Noji, Takehiro, Hida, Yasuhiro, Kaga, Kichizo, Matsui, Yoshiro, Ikeda, Hiroaki, Kageyama, Shinichi, Shiku, Hiroshi, Hirano, Satoshi
Published in International journal of oncology (01.08.2018)
Published in International journal of oncology (01.08.2018)
Get full text
Journal Article
HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan
KITANO, Shigehisa, KAGEYAMA, Shinichi, NISHIKAWA, Masakatsu, SUNAMOTO, Junzo, AKIYOSHI, Kazunari, KANEMATSU, Takashi, SCOTT, Andrew M, MURPHY, Roger, HOFFMAN, Eric W, OLD, Lloyd J, SHIKU, Hiroshi, NAGATA, Yasuhiro, MIYAHARA, Yoshihiro, HIASA, Atsunori, NAOTA, Hiroaki, OKUMURA, Satoshi, IMAI, Hiroshi, SHIRAISHI, Taizo, MASUYA, Masahiro
Published in Clinical cancer research (15.12.2006)
Published in Clinical cancer research (15.12.2006)
Get full text
Journal Article
2015 Guidance on cancer immunotherapy development in early‐phase clinical studies
Arato, Teruyo, Daimon, Takashi, Heike, Yuji, Ishii, Ken, Itho, Kyogo, Kageyama, Shinichi, Kawakami, Yutaka, Nakayama, Eiichi, Ozawa, Keiya, Sato, Noriyuki, Shiku, Hiroshi, Takeuchi, Masahiro, Tani, Kenzaburo, Tamada, Koji, Ueda, Ryuzo, Yamaguchi, Yoshiyuki, Yamanaka, Takeharu, Yamaue, Hiroki, Yasukawa, Masaki, Iguchi, Toyotaka, Kitano, Shigehisa, Miyahara, Yoshihiro, Nagata, Yasuhiro, Noguchi, Masanori, Terashima, Takeshi, Asano, Takeo, Asonuma, Motohiro, Ikeda, Hiroaki, Kakimi, Kazuhiro, Takesako, Kazutoh, Tanaka, Masanori, Amakasu, Kohei, Yamada, Akira, Harada, Naozumi, Aoshi, Taiki, Kuroda, Etsushi, Kobiyama, Kouji, Muraoka, Daisuke, Yamazaki, Naoya, Kuchiba, Aya, Tanaka, Shiro, Michimae, Hirofumi, Yamada, Tomomi, Hanada, Kenichi, Okada, Hideho, Takebe, Naoko, Hirano, Naoto, Okumura, Satoshi, Sato, Daisaku, Shibatsuji, Masayoshi, Yamaguchi, Teruhide
Published in Cancer science (01.12.2015)
Published in Cancer science (01.12.2015)
Get full text
Journal Article
Attempt to Harvest a Sufficient Number of Mononuclear Cells in an Appropriate Blood Product Volume By Modification of the Default Apheresis Setting
Tanaka, Yumi, Ohishi, Kohshi, Sawai, Toshiki, Iwasaki, Hitoshi, Kageyama, Shinichi, Masuya, Masahiro, Matsumoto, Takeshi, Tanigawa, Takashi, Wada, Hideo, Shiku, Hiroshi, Ito, Masaaki, Katayama, Naoyuki
Published in Therapeutic apheresis and dialysis (01.10.2017)
Published in Therapeutic apheresis and dialysis (01.10.2017)
Get full text
Journal Article
Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study
Ohtake, Shigeki, Miyawaki, Shuichi, Kiyoi, Hitoshi, Miyazaki, Yasushi, Okumura, Hirokazu, Matsuda, Shin, Nagai, Tadashi, Kishimoto, Yuji, Okada, Masaya, Takahashi, Masatomo, Handa, Hiroshi, Takeuchi, Jin, Kageyama, Shinichi, Asou, Norio, Yagasaki, Fumiharu, Maeda, Yasuhiro, Ohnishi, Kazunori, Naoe, Tomoki, Ohno, Ryuzo
Published in International journal of hematology (01.03.2010)
Published in International journal of hematology (01.03.2010)
Get full text
Journal Article
Limited expression of cancer-testis antigens in renal cell carcinoma patients
SOGA, NORIHITO, HORI, YASUHIDE, YAMAKADO, KOICHIRO, IKEDA, HIROAKI, IMAI, NAOKO, KAGEYAMA, SHINICHI, NAKASE, KAZUNORI, YUTA, ATSUSHI, HAYASHI, NORIO, SHIKU, HIROSHI, SUGIMURA, YOSHIKI
Published in Molecular and clinical oncology (01.03.2013)
Published in Molecular and clinical oncology (01.03.2013)
Get full text
Journal Article